1. Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
- Author
-
Kim YJ, Kim SI, Kim YR, Hong KW, Wie SH, Park YJ, Jeong H, and Kang MW
- Subjects
- Acinetobacter Infections epidemiology, Acinetobacter baumannii drug effects, Acinetobacter baumannii genetics, Acinetobacter baumannii isolation & purification, Adult, Aged, Aged, 80 and over, Chi-Square Distribution, Cluster Analysis, Cross Infection epidemiology, Electrophoresis, Gel, Pulsed-Field, Female, Humans, Imipenem pharmacology, Male, Meropenem, Microbial Sensitivity Tests, Middle Aged, Molecular Epidemiology, Republic of Korea epidemiology, Risk Factors, Statistics, Nonparametric, Thienamycins pharmacology, beta-Lactam Resistance, Acinetobacter Infections microbiology, Acinetobacter baumannii physiology, Anti-Bacterial Agents pharmacology, Carbapenems pharmacology, Cross Infection microbiology
- Abstract
Carbapenem-resistant Acinetobacter baumannii (CRAB) are an increasing infectious threat in hospitals. We investigated the clinical epidemiology of CRAB infections vs. colonization in patients, and examined the mechanisms of resistance associated with elevated minimum inhibitory concentrations (MICs) for carbapenems. From January to June 2009, 75 CRAB strains were collected. CRAB infection was significantly associated with malignancy and a high APACHE II score. The most dominant resistance mechanism was ISAba1 preceding OXA-51, producing strains with overexpression of efflux pump. Strains carrying blaOXA-23-like enzymes had higher carbapenem MICs than those carrying blaOXA-51-like enzymes; however, the presence of multiple mechanisms did not result in increased resistance to carbapenems. There was no difference in the resistance mechanisms in strains from infected and colonized patients. The majority of strains were genetically diverse by DNA macrorestriction although there was evidence of clonal spread of four clusters of strains in patients.
- Published
- 2012
- Full Text
- View/download PDF